Compare · BLCO vs WRBY
BLCO vs WRBY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- BLCO is the larger of the two at $5.51B, about 2.0x WRBY ($2.79B).
- Over the past year, BLCO is up 29.4% and WRBY is up 1.1% - BLCO leads by 28.3 points.
- BLCO has been more active in the news (16 items in the past 4 weeks vs 7 for WRBY).
- WRBY has more recent analyst coverage (25 ratings vs 18 for BLCO).
- Company
- Bausch + Lomb Corporation
- Warby Parker Inc.
- Price
- $15.48+0.72%
- $22.73-5.72%
- Market cap
- $5.51B
- $2.79B
- 1M return
- -3.25%
- +3.22%
- 1Y return
- +29.43%
- +1.09%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- 2021
- News (4w)
- 16
- 7
- Recent ratings
- 18
- 25
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest BLCO
- SEC Form SD filed by Bausch + Lomb Corporation
- Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
- Director Von Eschenbach Andrew C. was granted 15,842 shares, increasing direct ownership by 22% to 86,656 units (SEC Form 4)
- Director Ross Thomas W. Sr. was granted 15,842 shares, increasing direct ownership by 23% to 85,233 units (SEC Form 4)
- Director Robertson Russel C was granted 15,842 shares, increasing direct ownership by 20% to 94,260 units (SEC Form 4)
- Director Paulson John was granted 15,842 shares, increasing direct ownership by 21% to 89,823 units (SEC Form 4)
- Director Ling Karen was granted 15,842 shares, increasing direct ownership by 35% to 61,518 units (SEC Form 4)
- Director Kavanagh Sarah B was granted 15,842 shares, increasing direct ownership by 30% to 69,541 units (SEC Form 4)
- Director Collis Steven H was granted 15,842 shares, increasing direct ownership by 61% to 42,003 units (SEC Form 4)
- Director Bernier Nathalie D. was granted 15,842 shares, increasing direct ownership by 23% to 85,505 units (SEC Form 4)
Latest WRBY
- Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
- Co-Chief Executive Officer Gilboa David Abraham converted options into 20,799 shares and covered exercise/tax liability with 11,505 shares, increasing direct ownership by 18% to 59,587 units (SEC Form 4) (withholding tax)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 20,799 shares and covered exercise/tax liability with 11,505 shares, increasing direct ownership by 19% to 59,459 units (SEC Form 4) (tax withholding)
- Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.
- Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference
- Co-Chief Executive Officer Blumenthal Neil Harris sold $1,893,091 worth of shares (63,040 units at $30.03) as part of a pre-agreed trading plan and converted options into 63,040 shares (SEC Form 4)
- Warby Parker Unveils First Intelligent Eyewear Design
- Director Singer Bradley E sold $715,166 worth of shares (25,000 units at $28.61) (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Telsey Advisory Group reiterated coverage on Warby Parker with a new price target